{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:33:38Z","timestamp":1791999218732,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00428-020-02963-w","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T15:02:54Z","timestamp":1604588574000},"page":"757-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor"],"prefix":"10.1007","volume":"478","author":[{"given":"Lulu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Dehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio M.","family":"Maluf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7138-0923","authenticated-orcid":false,"given":"John S. A.","family":"Chrisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"issue":"1","key":"2963_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, O'Connell JX, Rosenberg AE, Rubin BP, Sweet DE, Vinh TN, Wold LE, Wehrli BM, White KE, Zaino RJ, Weiss SW (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28(1):1\u201330","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2963_CR2","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98(11):6500\u20136505. https:\/\/doi.org\/10.1073\/pnas.101545198","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2963_CR3","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren \u00d6, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, J\u00fcppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348(17):1656\u20131663. https:\/\/doi.org\/10.1056\/NEJMoa020881","journal-title":"N Engl J Med"},{"key":"2963_CR4","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","volume":"3","author":"S Minisola","year":"2017","unstructured":"Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Prim 3:17044\u201317044. https:\/\/doi.org\/10.1038\/nrdp.2017.44","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"2963_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/BPB.0b013e32832f59cb","volume":"19","author":"GH Jung","year":"2010","unstructured":"Jung GH, Kim JD, Cho Y, Chung SH, Lee JH, Sohn KR (2010) A 9-month-old phosphaturic mesenchymal tumor mimicking the intractable rickets. J Pediatr Orthop B 19(1):127\u2013132. https:\/\/doi.org\/10.1097\/BPB.0b013e32832f59cb","journal-title":"J Pediatr Orthop B"},{"issue":"9","key":"2963_CR6","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1097\/PAS.0b013e3181aa2311","volume":"33","author":"A Bahrami","year":"2009","unstructured":"Bahrami A, Weiss SW, Montgomery E, Horvai AE, Jin L, Inwards CY, Folpe AL (2009) RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia. Am J Surg Pathol 33(9):1348\u20131354. https:\/\/doi.org\/10.1097\/PAS.0b013e3181aa2311","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2963_CR7","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","volume":"59","author":"N Weidner","year":"1987","unstructured":"Weidner N, Cruz DS (1987) Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer 59(8):1442\u20131454. https:\/\/doi.org\/10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","journal-title":"Cancer"},{"issue":"1","key":"2963_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/pas.0000000000000290","volume":"39","author":"JM Carter","year":"2015","unstructured":"Carter JM, Caron BL, Dogan A, Folpe AL (2015) A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors. Am J Surg Pathol 39(1):75\u201383. https:\/\/doi.org\/10.1097\/pas.0000000000000290","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2963_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s002560000306","volume":"30","author":"A Ogose","year":"2001","unstructured":"Ogose A, Hotta T, Emura I, Hatano H, Inoue Y, Umezu H, Endo N (2001) Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia. Skelet Radiol 30(2):99\u2013103. https:\/\/doi.org\/10.1007\/s002560000306","journal-title":"Skelet Radiol"},{"issue":"9","key":"2963_CR10","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/lary.21916","volume":"121","author":"D Sidell","year":"2011","unstructured":"Sidell D, Lai C, Bhuta S, Barnes L, Chhetri DK (2011) Malignant phosphaturic mesenchymal tumor of the larynx. Laryngoscope 121(9):1860\u20131863. https:\/\/doi.org\/10.1002\/lary.21916","journal-title":"Laryngoscope"},{"issue":"11","key":"2963_CR11","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1016\/j.humpath.2013.04.027","volume":"44","author":"K Uchihashi","year":"2013","unstructured":"Uchihashi K, Nishijima-Matsunobu A, Matsuyama A, Yamasaki F, Tanabe T, Uemura T, Aragane N, Yakushiji M, Yamamoto M, Aoki S, Toda S (2013) Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis. Hum Pathol 44(11):2614\u20132618. https:\/\/doi.org\/10.1016\/j.humpath.2013.04.027","journal-title":"Hum Pathol"},{"issue":"1","key":"2963_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.anl.2008.01.003","volume":"36","author":"N Uramoto","year":"2009","unstructured":"Uramoto N, Furukawa M, Yoshizaki T (2009) Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue. Auris Nasus Larynx 36(1):104\u2013105. https:\/\/doi.org\/10.1016\/j.anl.2008.01.003","journal-title":"Auris Nasus Larynx"},{"issue":"10","key":"2963_CR13","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/pas.0000000000000890","volume":"41","author":"A Agaimy","year":"2017","unstructured":"Agaimy A, Michal M, Chiosea S, Petersson F, Hadravsky L, Kristiansen G, Horch RE, Schmolders J, Hartmann A, Haller F, Michal M (2017) Phosphaturic mesenchymal tumors: clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic spectrum. Am J Surg Pathol 41(10):1371\u20131380. https:\/\/doi.org\/10.1097\/pas.0000000000000890","journal-title":"Am J Surg Pathol"},{"issue":"17","key":"2963_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000006750","volume":"96","author":"S Qiu","year":"2017","unstructured":"Qiu S, Cao LL, Qiu Y, Yan P, Li ZX, Du J, Sun LM, Zhang QF (2017) Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: a case report. Medicine (Baltimore) 96(17):e6750. https:\/\/doi.org\/10.1097\/md.0000000000006750","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2963_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3892\/ol.2014.2081","volume":"8","author":"T Morimoto","year":"2014","unstructured":"Morimoto T, Takenaka S, Hashimoto N, Araki N, Myoui A, Yoshikawa H (2014) Malignant phosphaturic mesenchymal tumor of the pelvis: a report of two cases. Oncol Lett 8(1):67\u201371. https:\/\/doi.org\/10.3892\/ol.2014.2081","journal-title":"Oncol Lett"},{"issue":"1","key":"2963_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12891-017-1446-z","volume":"18","author":"R Arai","year":"2017","unstructured":"Arai R, Onodera T, Terkawi MA, Mitsuhashi T, Kondo E, Iwasaki N (2017) A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia. BMC Musculoskelet Disord 18(1):79. https:\/\/doi.org\/10.1186\/s12891-017-1446-z","journal-title":"BMC Musculoskelet Disord"},{"key":"2963_CR17","doi-asserted-by":"publisher","unstructured":"Folpe AL (2019) Phosphaturic mesenchymal tumors: a review and update, vol 36. W.B. Saunders. https:\/\/doi.org\/10.1053\/j.semdp.2019.07.002","DOI":"10.1053\/j.semdp.2019.07.002"},{"issue":"4","key":"2963_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00402-008-0808-2","volume":"129","author":"R Seijas","year":"2009","unstructured":"Seijas R, Ares O, Sierra J, P\u00e9rez-Dominguez M (2009) Oncogenic osteomalacia: two case reports with surprisingly different outcomes. Arch Orthop Trauma Surg 129(4):533\u2013539. https:\/\/doi.org\/10.1007\/s00402-008-0808-2","journal-title":"Arch Orthop Trauma Surg"},{"issue":"3","key":"2963_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1440-1827.1996.tb03605.x","volume":"46","author":"T Tsujimura","year":"1996","unstructured":"Tsujimura T, Sakaguchi K, Aozasa K (1996) Phosphaturic mesenchymal tumor, mixed connective tissue variant (oncogenic osteomalacia). Pathol Int 46(3):238\u2013241. https:\/\/doi.org\/10.1111\/j.1440-1827.1996.tb03605.x","journal-title":"Pathol Int"},{"key":"2963_CR20","doi-asserted-by":"publisher","unstructured":"Yamada Y, Kinoshita I, Kohashi K, Yamamoto H, Iwasaki T, Otsuka H, Yoshimoto M, Ishihara S, Toda Y, Kuma Y, Setsu N, Koga Y, Honda Y, Inoue T, Yanai H, Yamashita K, Ito I, Takahashi M, Ohga S, Furue M, Nakashima Y, Oda Y (2017) Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant. https:\/\/doi.org\/10.1111\/his.13377","DOI":"10.1111\/his.13377"},{"key":"2963_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.humpath.2018.02.022","volume":"80","author":"KN Sent-Doux","year":"2018","unstructured":"Sent-Doux KN, Mackinnon C, Lee JC, Folpe AL, Habeeb O (2018) Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the \u201cnonphosphaturic\u201d variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization. Hum Pathol 80:94\u201398. https:\/\/doi.org\/10.1016\/j.humpath.2018.02.022","journal-title":"Hum Pathol"},{"issue":"3","key":"2963_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12105-015-0678-1","volume":"10","author":"JK Wasserman","year":"2016","unstructured":"Wasserman JK, Purgina B, Lai CK, Gravel D, Mahaffey A, Bell D, Chiosea SI (2016) Phosphaturic mesenchymal tumor involving the head and neck: a report of five cases with FGFR1 fluorescence in situ hybridization analysis. Head Neck Pathol 10(3):279\u2013285. https:\/\/doi.org\/10.1007\/s12105-015-0678-1","journal-title":"Head Neck Pathol"},{"issue":"6","key":"2963_CR23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00256-013-1798-x","volume":"43","author":"MC Koplas","year":"2014","unstructured":"Koplas MC, Rubin BP, Sundaram M (2014) Phosphaturic mesenchymal tumor: two contrasting cases. Skelet Radiol 43(6):841\u2013845. https:\/\/doi.org\/10.1007\/s00256-013-1798-x","journal-title":"Skelet Radiol"},{"issue":"6","key":"2963_CR24","first-page":"7506","volume":"8","author":"DA Shustik","year":"2015","unstructured":"Shustik DA, Ng DC, Sittampalam K (2015) Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings. Int J Clin Exp Pathol 8(6):7506\u20137517","journal-title":"Int J Clin Exp Pathol"},{"issue":"11","key":"2963_CR25","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/jclinpath-2016-203893","volume":"69","author":"D Creytens","year":"2016","unstructured":"Creytens D, Van Dorpe J (2016) DOG1 expression in phosphaturic mesenchymal tumour. J Clin Pathol 69(11):1037\u20131038. https:\/\/doi.org\/10.1136\/jclinpath-2016-203893","journal-title":"J Clin Pathol"},{"issue":"7","key":"2963_CR26","first-page":"8159","volume":"8","author":"S Tajima","year":"2015","unstructured":"Tajima S, Fukayama M (2015) CD56 may be a more useful immunohistochemical marker than somatostatin receptor 2A for the diagnosis of phosphaturic mesenchymal tumors. Int J Clin Exp Pathol 8(7):8159\u20138164","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"2963_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00795-015-0115-2","volume":"49","author":"S Tajima","year":"2016","unstructured":"Tajima S, Takashi Y, Ito N, Fukumoto S, Fukuyama M (2016) ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors. Med Mol Morphol 49(4):203\u2013209. https:\/\/doi.org\/10.1007\/s00795-015-0115-2","journal-title":"Med Mol Morphol"},{"issue":"12","key":"2963_CR28","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","volume":"44","author":"M Houang","year":"2013","unstructured":"Houang M, Clarkson A, Sioson L, Elston MS, Clifton-Bligh RJ, Dray M, Ranchere-Vince D, Decouvelaere AV, De La Fouchardiere A, Gill AJ (2013) Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Hum Pathol 44(12):2711\u20132718. https:\/\/doi.org\/10.1016\/j.humpath.2013.07.016","journal-title":"Hum Pathol"},{"issue":"4","key":"2963_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/path.4465","volume":"235","author":"J-C Lee","year":"2015","unstructured":"Lee J-C, Jeng Y-M, Su S-Y, Wu C-T, Tsai K-S, Lee C-H, Lin C-Y, Carter JM, Huang J-W, Chen S-H, Shih S-R, Mari\u00f1o-Enr\u00edquez A, Chen C-C, Folpe AL, Chang Y-L, Liang C-W (2015) Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol 235(4):539\u2013545. https:\/\/doi.org\/10.1002\/path.4465","journal-title":"J Pathol"},{"issue":"11","key":"2963_CR30","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","volume":"29","author":"J-C Lee","year":"2016","unstructured":"Lee J-C, Su S-Y, Changou CA, Yang R-S, Tsai K-S, Collins MT, Orwoll ES, Lin C-Y, Chen S-H, Shih S-R, Lee C-H, Oda Y, Billings SD, Li C-F, Nielsen GP, Konishi E, Petersson F, Carpenter TO, Sittampalam K, Huang H-Y, Folpe AL (2016) Characterization of FN1\u2013FGFR1 and novel FN1\u2013FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Mod Pathol 29(11):1335\u20131346. https:\/\/doi.org\/10.1038\/modpathol.2016.137","journal-title":"Mod Pathol"},{"issue":"5","key":"2963_CR31","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41379-019-0416-4","volume":"33","author":"CH Lee","year":"2019","unstructured":"Lee CH, Su SY, Sittampalam K, Chen PCH, Petersson F, Kao YC, Carpenter TO, Hsieh TH, Konishi E, Tsai JW, Billings SD, Folpe AL, Lee JC (2019) Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications. Mod Pathol 33(5):858\u2013870. https:\/\/doi.org\/10.1038\/s41379-019-0416-4","journal-title":"Mod Pathol"},{"key":"2963_CR32","doi-asserted-by":"publisher","unstructured":"Haas BJ, Dobin A, Stransky N, Li B, Yang X, Tickle T, Bankapur A, Ganote C, Doak TG, Pochet N, Sun J, Wu CJ, Gingeras TR, Regev A (2017) STAR-Fusion: fast and accurate fusion transcript detection from RNA-Seq. bioRxiv 120295-120295. https:\/\/doi.org\/10.1101\/120295","DOI":"10.1101\/120295"},{"issue":"2","key":"2963_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/EJE-07-0485","volume":"158","author":"FM Hannan","year":"2008","unstructured":"Hannan FM, Athanasou NA, Teh J, Gibbons CLMH, Shine B, Thakker RV (2008) Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. Eur J Endocrinol 158(2):265\u2013271. https:\/\/doi.org\/10.1530\/EJE-07-0485","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2963_CR34","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1210\/jc.2016-2052","volume":"101","author":"D El-Maouche","year":"2016","unstructured":"El-Maouche D, Sadowski SM, Papadakis GZ, Guthrie L, Cottle-Delisle C, Merkel R, Millo C, Chen CC, Kebebew E, Collins MT (2016) (68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia. J Clin Endocrinol Metab 101(10):3575\u20133581. https:\/\/doi.org\/10.1210\/jc.2016-2052","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2963_CR35","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/jbmr.1881","volume":"28","author":"WH Chong","year":"2013","unstructured":"Chong WH, Andreopoulou P, Chen CC, Reynolds J, Guthrie L, Kelly M, Gafni RI, Bhattacharyya N, Boyce AM, El-Maouche D, Crespo DO, Sherry R, Chang R, Wodajo FM, Kletter GB, Dwyer A, Collins MT (2013) Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res Off J Am Soc Bone Miner Res 28(6):1386\u20131398. https:\/\/doi.org\/10.1002\/jbmr.1881","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"12","key":"2963_CR36","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1038\/s41379-019-0315-8","volume":"32","author":"F Amary","year":"2019","unstructured":"Amary F, Perez-Casanova L, Ye H, Cottone L, Strobl AC, Cool P, Miranda E, Berisha F, Aston W, Rocha M, O\u2019Donnell P, Pillay N, Tirabosco R, Baumhoer D, Hookway ES, Flanagan AM (2019) Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement. Mod Pathol 32(12):1762\u20131771. https:\/\/doi.org\/10.1038\/s41379-019-0315-8","journal-title":"Mod Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02963-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-020-02963-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02963-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T03:05:32Z","timestamp":1616641532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-020-02963-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2963"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-02963-w","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"6 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Washington University School of Medicine institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}